Kuhlmann Shirley R.'s Form 4 filing
Collegium Pharmaceutical, Inc (COLL) · filed Feb 14, 2023
- Accession no.
- 0001062993-23-003479
- Filed
- Feb 14, 2023
- Trade date
- Feb 10-13, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market sales total $586.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kuhlmann Shirley R.CIK 0001734919 | Officer (EVP and General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2023 | Common Stock | AGrant or awardAcquired | +48,125 | $0.00 | $0 | 157,620 | Direct | |
| Feb 10, 2023 | Common Stock | AGrant or awardAcquired | +25,739 | – | – | 183,359 | Direct | |
| Feb 10, 2023 | Common Stock | FTax withholdingDisposed | −16,291 | $26.75 | −$435,784.25 | 167,068 | Direct | |
| Feb 10, 2023 | Common Stock | FTax withholdingDisposed | −7,755 | $26.75 | −$207,446.25 | 159,313 | Direct | |
| Feb 13, 2023 | Common Stock | SSaleDisposed | −21,811 | $26.88 | −$586,279.68 | 137,502 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.